Cargando...
CNS Demyelination with TNF-α Blockers
Tumor necrosis factor–α (TNF-α) blockers are a popular therapeutic choice in a number of inflammatory diseases. Thus far, five TNF- α blockers have been approved for clinical use (etanercept, infliximab, adalimumab, golimumab. and certolizumab). Despite being considered relatively safe, serious side...
Gardado en:
| Publicado en: | Curr Neurol Neurosci Rep |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer US
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5364240/ https://ncbi.nlm.nih.gov/pubmed/28337644 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11910-017-0742-1 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|